Diabetes remission linked to fewer cardiovascular events, but mortality link stays uncertain

People with type 2 diabetes who achieve remission may face a lower long-term risk of cardiovascular events, according to a new systematic review and meta-analysis published in Diabetology & Metabolic Syndrome. The review, led by Hao Bai and colleagues, pooled data from longitudinal studies that followed adults with type 2 diabetes over time, comparing those who achieved remission with those who did not achieve or maintain it.

The research team searched PubMed, Embase, Web of Science, and Scopus from inception to July 20, 2026, without language restrictions. To be eligible, studies had to include adults with type 2 diabetes, assess remission before outcome ascertainment, compare participants who achieved remission with those who did not, and report an adjusted effect estimate after at least 12 months of follow-up.

Ten studies met the eligibility criteria, and nine of them contributed data to the quantitative synthesis. The researchers pooled adjusted hazard ratios using random-effects models and assessed methodological quality with the Newcastle–Ottawa Scale. The certainty of the evidence was evaluated using the GRADE approach.

The headline finding concerned cardiovascular events. Across five studies, remission was associated with a lower hazard of cardiovascular events, with a pooled hazard ratio of 0.68 (95% confidence interval, 0.59–0.80) and low heterogeneity between studies (I² = 11.7%). This was the most consistent result in the analysis, and the certainty of evidence for this outcome was rated as low.

The picture was less clear for other outcomes. Remission was not significantly associated with all-cause mortality in three studies, with a pooled hazard ratio of 0.80 (95% CI, 0.53–1.21) and substantial heterogeneity (I² = 65.0%). The certainty of evidence for mortality was rated as very low, meaning the true association remains uncertain.

For microvascular complications, five studies yielded a pooled hazard ratio of 0.60 (95% CI, 0.38–0.93), suggesting a lower hazard, but the heterogeneity was very high (I² = 93.4%), and the certainty of evidence was very low. An exploratory analysis of broader macrovascular complications, drawing on six studies, also suggested a lower hazard (HR, 0.74; 95% CI, 0.58–0.93), though substantial heterogeneity (I² = 75.6%) again limited confidence in the estimate.

Sensitivity analyses did not materially alter the overall direction of the pooled estimates, the authors report. However, they emphasize that the findings should not be interpreted as evidence of causality. Because the underlying studies were observational and longitudinal rather than randomized trials, the associations could be influenced by differences between people who achieve remission and those who do not.

The authors conclude that type 2 diabetes remission is associated with lower pooled hazards of cardiovascular events, while the associations with microvascular and macrovascular complications are less certain due to substantial heterogeneity and limited precision. The association with all-cause mortality remains uncertain.

Importantly, the review’s conclusions carry a practical caution: even after remission, long-term glycemic monitoring, comprehensive risk-factor management, and surveillance for diabetes-related complications should continue. Remission, in other words, is not a cure, and the evidence reviewed here describes prognostic associations rather than guaranteed protection. The article was published open access on October 22, 2026, and is a peer-reviewed, accepted version shared ahead of the final Version of Record.

Subject of Research: Associations of type 2 diabetes remission with mortality and vascular outcomes

Article Title: Association of Type 2 diabetes remission with mortality and vascular outcomes: a systematic review and meta-analysis of longitudinal studies

Article References: Bai, H., Song, L., Zhan, Y., Dai, L., He, Q., Duan, J., Yang, H., Liao, L., & Huang, R. (2026). Association of Type 2 diabetes remission with mortality and vascular outcomes: a systematic review and meta-analysis of longitudinal studies. Diabetology & Metabolic Syndrome. https://doi.org/10.1186/s13098-026-02314-w

Image Credits: AI Generated

DOI: 10.1186/s13098-026-02314-w

Keywords: type 2 diabetes, diabetes remission, meta-analysis, systematic review, cardiovascular events, all-cause mortality, microvascular complications, macrovascular complications, hazard ratio, GRADE certainty, observational studies, Association